Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation

被引:17
作者
Bosch, Nicholas A. [1 ]
Rucci, Justin M. [1 ]
Massaro, Joseph M. [2 ]
Winter, Michael R. [3 ]
Quinn, Emily K. [3 ]
Chon, Ki H. [4 ]
McManus, David D. [5 ]
Walkey, Allan J. [1 ]
机构
[1] Boston Univ, Sch Med, Dept Med, Pulm Ctr, Boston, MA 02118 USA
[2] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA
[3] Boston Univ, Sch Publ Hlth, Biostat & Epidemiol Data Analyt Ctr, Boston, MA 02118 USA
[4] Univ Connecticut, Dept Biomed Engn, Mansfield, PA USA
[5] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA USA
基金
美国国家卫生研究院;
关键词
atrial fibrillation; comparative effectiveness; rate control; sepsis; CRITICALLY-ILL PATIENTS; OUTCOMES;
D O I
10.1016/j.chest.2020.10.049
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Atrial fibrillation (AF) with rapid ventricular response frequently complicates the management of critically ill patients with sepsis and may necessitate the initiation of medication to avoid hemodynamic compromise. However, the optimal medication to achieve rate control for AF with rapid ventricular response in sepsis is unclear. RESEARCH QUESTION: What is the comparative effectiveness of frequently used AF medications ((3-blockers, calcium channel blockers, amiodarone, and digoxin) on heart rate (HR) reduction among critically ill patients with sepsis and AF with rapid ventricular response? STUDY DESIGN AND METHODS: We conducted a multicenter retrospective cohort study among patients with sepsis and AF with rapid ventricular response (HR 110 beats/min). We compared the rate control effectiveness of (3-blockers to calcium channel blockers, amiodarone, and digoxin using multivariate-adjusted, time-varying exposures in competing risk models (for death and addition of another AF medication), adjusting for fixed and time varying confounders. RESULTS: Among 666 included patients, 50.6% initially received amiodarone, 10.1% received a (3-blocker, 33.8% received a calcium channel blocker, and 5.6% received digoxin. The adjusted hazard ratio for HR of < 110 beats/min by 1 h was 0.50 (95% CI, 0.34-0.74) for amiodarone vs (3-blocker, 0.37 (95% CI, 0.18-0.77) for digoxin vs (3-blocker, and 0.75 (95% CI, 0.51-1.11) for calcium channel blocker vs (3-blocker. By 6 h, the adjusted hazard ratio for HR < 110 beats/min was 0.67 (95% CI, 0.47-0.97) for amiodarone vs (3-blocker, 0.60 (95% CI, 0.36-1.004) for digoxin vs (3-blocker, and 1.03 (95% CI, 0.71-1.49) for calcium channel blocker vs (3-blocker. INTERPRETATION: In a large cohort of patients with sepsis and AF with rapid ventricular response, a (3-blocker treatment strategy was associated with improved HR control at 1 h, but generally similar HR control at 6 h compared with amiodarone, calcium channel blocker, or digoxin.
引用
收藏
页码:1452 / 1459
页数:8
相关论文
共 16 条
[1]   PhysioBank, PhysioToolkit, and PhysioNet - Components of a new research resource for complex physiologic signals [J].
Goldberger, AL ;
Amaral, LAN ;
Glass, L ;
Hausdorff, JM ;
Ivanov, PC ;
Mark, RG ;
Mietus, JE ;
Moody, GB ;
Peng, CK ;
Stanley, HE .
CIRCULATION, 2000, 101 (23) :E215-E220
[2]   Using the E-Value to Assess the Potential Effect of Unmeasured Confounding in Observational Studies [J].
Haneuse, Sebastien ;
VanderWeele, Tyler J. ;
Arterburn, David .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (06) :602-603
[3]   Identifying Patients With Severe Sepsis Using Administrative Claims Patient-Level Validation of the Angus Implementation of the International Consensus Conference Definition of Severe Sepsis [J].
Iwashyna, Theodore J. ;
Odden, Andrew ;
Rohde, Jeffrey ;
Bonham, Catherine ;
Kuhn, Latoya ;
Malani, Preeti ;
Chen, Lena ;
Flanders, Scott .
MEDICAL CARE, 2014, 52 (06) :E39-E43
[4]  
January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI [10.1016/j.jacc.2019.01.011, 10.1161/CIR.0000000000000665]
[5]   Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients [J].
Kanji, Salmaan ;
Williamson, David R. ;
Yaghchi, Behrooz Mohammadzadeh ;
Albert, Martin ;
McIntyre, Lauralyn .
JOURNAL OF CRITICAL CARE, 2012, 27 (03) :326.e1-326.e8
[6]  
Klouwenberg PMCK, 2017, AM J RESP CRIT CARE, V195, P205, DOI [10.1164/rccm.201603-06180C, 10.1164/rccm.201603-0618OC]
[7]   MANAGEMENT OF ATRIAL FIBRILLATION WITH RAPID VENTRICULAR RESPONSE IN THE INTENSIVE CARE UNIT: A SECONDARY ANALYSIS OF ELECTRONIC HEALTH RECORD DATA [J].
Moskowitz, Ari ;
Chen, Kenneth P. ;
Cooper, Avraham Z. ;
Chahin, Abdullah ;
Ghassemi, Mohammad M. ;
Celi, Leo Anthony .
SHOCK, 2017, 48 (04) :436-440
[8]   The eICU Collaborative Research Database, a freely available multi-center database for critical care research [J].
Pollard, Tom J. ;
Johnson, Alistair E. W. ;
Raffa, Jesse D. ;
Celi, Leo A. ;
Mark, Roger G. ;
Badawi, Omar .
SCIENTIFIC DATA, 2018, 5
[9]  
Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
[10]  
Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337